Families of children with severe hemophilia A may want to take a fresh look at treatment options from human plasma. A study published in the New England Journal of Medicine on May 26 showed that participants who received ...
Jun 13, 2016
0
1
(HealthDay)—In a case report published online April 11 in the Journal of Diabetes Investigation, researchers document rapid-onset insulin-dependent diabetes in an Asian patient undergoing treatment with anti-programmed ...
Apr 25, 2016
0
2
(HealthDay)—Raplixa (human fibrin sealant) has been approved by the U.S. Food and Drug Administration to help control bleeding during surgery, the agency said in a news release.
May 4, 2015
0
8
Where ALS comes from and how it progresses are mysteries that continue to vex medical science. But recent research at Sweden's KTH Royal Institute of Technology has found three proteins that could shed some light on the mechanisms ...
Mar 24, 2015
0
11
A study publishing February 26th, 2015 in PLOS Neglected Tropical Diseases describes a new, pragmatic, method for the production of immunoglobulin G (IgG) from human plasma in developing countries. IgG are therapeutic preparations ...
Feb 26, 2015
0
4
In a new study published in the Journal of Nutritional Biochemistry, Chen-Yu Zhang, Xi Chen and Ke Zen's group at Nanjing University systematically characterized the kinetics of plant microRNAs (miRNAs) in human plasma after ...
Feb 23, 2015
0
4
When you have your cholesterol checked, the doctor typically gives you levels of three fats found in the blood: LDL, HDL and triglycerides. But did you know your body contains thousands of other types of fats, or lipids?
Apr 29, 2013
0
0
With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body's inflammatory response and how malignant breast cancer cells use the bloodstream to spread.
Jan 23, 2013
0
1
(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.
Jan 17, 2013
0
0
A research team led by Dr. Christos Mantzoros, MD, PhD, at Beth Israel Deaconess Medical Center, Harvard Medical School, has published new findings elucidating the molecular and clinical role of FNDC5/irisin in humans.
Oct 1, 2012
0
0
